Hippo Signaling
Hippo signaling is a conserved pathway for organ size control by modulating cell proliferation, apoptosis and tissue-specific stem cell regeneration. It is associated with carcinogenesis.
Products Related to Hippo Signaling(8)
- GC14482VerteporfinCAS: 129497-78-5Purity: >98.00%
Verteporfin,a benzoporphyrin derivative monoacid ring A, is a photo-sensitizing agent for photodynamic therapy (PDT).
- GC32914EMT inhibitor-1CAS: 1638526-21-2Purity: >99.00%
EMT inhibitor-1 is an inhibitor of of Hippo, TGF-β, and Wnt signaling pathways with antitumor activities.
- GC69261IHMT-MST1-58CAS: 2414484-25-4Purity: >99.00%
IHMT-MST1-58 is an effective and selective inhibitor of STE20-like protein 1 kinase (MST1), with oral activity and an IC50 value of 23 nM. IHMT-MST1-58 can be used for research on type 1 or type 2 diabetes.
- GC81335MST3-IN-1 TFAPurity: >99.00%
MST3-IN-1 TFA (Compound LD-1) is a selective and orally active MST3 inhibitor, with an IC 50 of 122.4 nM.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC14482 | Verteporfin | 129497-78-5 | >98.00% | |
Verteporfin,a benzoporphyrin derivative monoacid ring A, is a photo-sensitizing agent for photodynamic therapy (PDT). | ||||
| GC11245 | XMU-MP-1 | 2061980-01-4 | >99.00% | |
XMU-MP-1 is a reversible and selective inhibitor of MST1/2 kinase, with IC 50s of 71.1±12.9 nM and 38.1±6.9 nM for MST1 and MST2 respectively. | ||||
| GC32914 | EMT inhibitor-1 | 1638526-21-2 | >99.00% | |
EMT inhibitor-1 is an inhibitor of of Hippo, TGF-β, and Wnt signaling pathways with antitumor activities. | ||||
| GC61410 | I3MT-3 | 459420-09-8 | >98.00% | |
I3MT-3 (HMPSNE) is a potent, selective, and cell-membrane permeable inhibitor of 3-Mercaptopyruvate sulfurtransferase (3MST) (IC50=2.7 μM). | ||||
| GC69261 | IHMT-MST1-58 | 2414484-25-4 | >99.00% | |
IHMT-MST1-58 is an effective and selective inhibitor of STE20-like protein 1 kinase (MST1), with oral activity and an IC50 value of 23 nM. IHMT-MST1-58 can be used for research on type 1 or type 2 diabetes. | ||||
| GC73860 | JA310 | 3022928-90-8 | >99.50% | |
JA310 is a highly selective MST3 kinase inhibitor. | ||||
| GC81335 | MST3-IN-1 TFA | - | >99.00% | |
MST3-IN-1 TFA (Compound LD-1) is a selective and orally active MST3 inhibitor, with an IC 50 of 122.4 nM. | ||||
| GC81337 | MR24 TFA | - | >99.00% | |
MR24 TFA, a G-5555 derivative, is a mammalian STE20-like ( MST ) kinase inhibitor. | ||||
